<DOC>
	<DOCNO>NCT01821079</DOCNO>
	<brief_summary>The purpose study healthy volunteer assess relative bioavailability PF-05175157 powder-in-capsule tablet formulation effect food pharmacokinetics tablet formulation .</brief_summary>
	<brief_title>A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive Women must non childbearing potential Body Mass Index ( BMI ) 25 35 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding Screening . Active ocular disease include infection , glaucoma , seasonal allergy , dry eye symptom , optic nerve disease retinal disease . History habitual smoking past 5 year history evidence habitual use ( non smoke ) tobacco nicotinecontaining product within 3 month Screening positive cotinine test Screening Day 0</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Single dose</keyword>
	<keyword>Relative Bioavailability</keyword>
	<keyword>Food effect</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>Diabetes Mellitus Type 2</keyword>
</DOC>